Doxylamine Succinate/Pyridoxine hydrochloride

琥珀酸多西拉敏/维生素B6

Report date: 2026/03/13 20:02:36

Base Information

Drug NameDoxylamine Succinate/Pyridoxine hydrochloride
Drug Alias Name维生素B6/琥珀酸多西拉敏Doxylamine Succinate/Vitamin B6Pyridoxine hydrochloride/Doxylamine SuccinatePyridoxine/DoxylamineBendectin +[6] 
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsVomitingNauseaHyperemesis Gravidarum
Global Approved IndicationsVomitingNausea
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1956/07/30
Country/TerritoryCanadaUnited StatesRussian Federation
CombinationsYes Vitamin B6Doxylamine Succinate
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSanofiDuchesnay Inc
China Registration ClassN/A

Develop Information

Active CompaniesValenta Pharm Jsc
Inactive CompaniesDuchesnay IncSanofi-Aventis U.S. Llc
Active IndicationsNausea
Inactive IndicationsVomitingHyperemesis Gravidarum

Other Information

ATC CodeR06AA59
Related LinksWikipedia